Special Purpose Acquisition Companies (SPACs)

Frequently Asked Questions

POEMS offers both SG and US SPACs.

Simply go to “Advanced search”, select “Stocks” for product and “SGX/NASDAQ/NYSE” market for exchange, and key in the keyword “SPAC”. To identify SPACs product, find the word “SPAC” behind the company’s name. For example: Pegasus SPAC.

SPACs have professional sponsors such as private equity firms whose mandate and expertise is investing into companies with a view towards a potential public listing. SPAC sponsors contribute sponsor equity and support operational expenses in the SPAC. This is in contrast with cash shell listed companies who may not have the necessary investment expertise nor the level of alignment of interest and support. Finally, SPACs are required to place at least 90% of the gross IPO proceeds in a trust/escrow account, providing safeguards for investors until the completion of the Business Combination.

Prior to the Business Combination, the SPAC entity is primarily a fund-raising vehicle governed under the SPAC framework. This provides a) alignment of interest between SPAC sponsors and independent shareholders and b) opportunities for investors to participate in private equity arrangements in a publicly listed company with the relevant investor protection considerations.
Upon completion of the Business Combination, the resulting entity is subjected to existing Listing Requirements – similar to a traditional IPO. Existing standards are equally applied to the resulting entity which will have an operational business post Business Combination (de-SPAC).

No. The Resulting Issuer (i.e. operating company acquired by a SPAC) is required to meet the same Initial Listing Requirement as a traditional IPO company seeking to list on the Mainboard; including the quantitative admission criterion, public spread and distribution requirements, and qualitative requirements such as the character and integrity of directors, executive officers and controlling shareholders.

The SGX SPAC framework references the US SPAC regime and as such certain features are identical. However, SGX SPACs further codify some of the market conventions with a focus on investor protection and alignment of interests of all stakeholders. SGX also places emphasis on a sponsor’s track record, reputation of founding shareholders and experience and expertise of the SPAC’s management team.

Category Requirement SGX US
General Market capitalisation Minimum of S$150 million (as per Mainboard rules) Minimum of USD50 million
Issue price Minimum of S$5 per unit USD2-4 per unit but SPAC issues typically at USD10 per unit
Public float At least 25% float and at least 300 shareholders for the SPAC. At least 25% float and at least 500 shareholders for the resulting issuer (post de-SPAC) At least 300 shareholders or 400 round lot holders depending on exchange
Minimum IPO gross proceeds in escrow account At least 90% At least 90%
Fair market value of initial acquisition relative to escrowed amount At least 80% At least 80%
Detachable warrants Permissible Permissible
Redemption rights Permissible for all independent shareholders Permissible for all independent shareholders
Timeframe for completion of business combination 24 months, with 12 months extension subject to fulfilment of prescribed conditions 36 months
Appointment of independent valuer for business combination Compulsary in the absence of PIPE financing, or where SPAC acquires a MOG or property investment/development target* No requirement
Investor protection and alignment of interests Minimum equity participation by Sponsor 2.5-3.5% depending on market capitalisation Commercially negotiated
Limit on Sponsor’s promote Up to 20% No limit
Moratorium on Sponsor’s shares from IPO to de-SPAC 6-month moratorium post de-SPAC and further 6-month moratorium thereafter on 50% of shareholders (for applicable resulting issuers) Commercially negotiated
Shareholders approval for business combination More than 50% of shareholders and 50% of independent directors More than 50% of shareholders
de-SPAC process Follows Mainboard Reverse Take-Over (RTO) rules Treated as merger
Maximum dilution arising from conversion of warrants 50% No limit

*SGX retains discretion to require the issuer to appoint a competent and independent valuer to value the businesses or assets to be acquired under the business combination.

SPACs enable an investor to participate in private equity arrangements (eg. high growth companies) in the form of a publicly listed company. This is based on an investor’s risk appetite and just like any other stocks, the investor can trade in the different stages of the life-cycle of a SPAC.

For more information, please visit SGX Website or contact your trading representatives.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com